Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
出版年份 2014 全文链接
标题
Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure
作者
关键词
-
出版物
NATURE MEDICINE
Volume 20, Issue 2, Pages 167-174
出版商
Springer Nature
发表日期
2014-01-13
DOI
10.1038/nm.3441
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Non-Cell-Autonomous Tumor Suppression by p53
- (2013) Amaia Lujambio et al. CELL
- Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha
- (2013) Rabab M. El Eit et al. INTERNATIONAL JOURNAL OF CANCER
- Lysosome-mediated processing of chromatin in senescence
- (2013) Andre Ivanov et al. JOURNAL OF CELL BIOLOGY
- Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies
- (2013) Julien Ablain et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- Lamin B1 loss is a senescence-associated biomarker
- (2012) Adam Freund et al. MOLECULAR BIOLOGY OF THE CELL
- Regulation of E2Fs and senescence by PML nuclear bodies
- (2011) M. Vernier et al. GENES & DEVELOPMENT
- Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
- (2011) Ardeshir Ghavamzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
- (2010) Marion Jeanne et al. CANCER CELL
- Transcriptome Analysis Reveals that p53 and -Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers
- (2010) B. Ragazzon et al. CANCER RESEARCH
- p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal
- (2010) Z. Zhao et al. GENES & DEVELOPMENT
- Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
- (2010) Vikram Mathews et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
- (2010) Hiba El Hajj et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Arsenic Trioxide Controls the Fate of the PML-RAR Oncoprotein by Directly Binding PML
- (2010) X. W. Zhang et al. SCIENCE
- PML Nuclear Bodies
- (2010) V. Lallemand-Breitenbach et al. Cold Spring Harbor Perspectives in Biology
- The coagulopathy of acute promyelocytic leukaemia revisited
- (2009) Eytan Stein et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
- (2009) G. Kchour et al. BLOOD
- Curing APL: Differentiation or Destruction?
- (2009) Scott C. Kogan CANCER CELL
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations
- (2008) T. Akagi et al. BLOOD
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
- (2008) M. A. Sanz et al. BLOOD
- The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse
- (2008) Rebecca C. Furze et al. FASEB JOURNAL
- PML targeting eradicates quiescent leukaemia-initiating cells
- (2008) Keisuke Ito et al. NATURE
- Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
- (2008) Valérie Lallemand-Breitenbach et al. NATURE CELL BIOLOGY
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started